Spire Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28
| Closed | -$1.98K | – | 2398 |
|
|
2025
Q1 | $1.98K | Sell |
28
-10
| -26% | -$707 | ﹤0.01% | 2279 |
|
|
2024
Q4 | $2.5K | Sell |
38
-115
| -75% | -$7.56K | ﹤0.01% | 2206 |
|
|
2024
Q3 | $10.8K | Sell |
153
-7
| -4% | -$492 | ﹤0.01% | 1605 |
|
|
2024
Q2 | $13.2K | Buy |
160
+77
| +93% | +$6.34K | ﹤0.01% | 1563 |
|
|
2024
Q1 | $7.25K | Sell |
83
-3
| -3% | -$262 | ﹤0.01% | 1817 |
|
|
2023
Q4 | $7.93K | Hold |
86
| – | – | ﹤0.01% | 1816 |
|
|
2023
Q3 | $7.61K | Buy |
86
+11
| +15% | +$973 | ﹤0.01% | 1813 |
|
|
2023
Q2 | $6.5K | Sell |
75
-26,289
| -100% | -$2.28M | ﹤0.01% | 1936 |
|
|
2023
Q1 | $2.56M | Buy |
26,364
+26,236
| +20,497% | +$2.55M | 0.1% | 200 |
|
|
2022
Q4 | $13K | Hold |
128
| – | – | ﹤0.01% | 1512 |
|
|
2022
Q3 | $11K | Hold |
128
| – | – | ﹤0.01% | 1527 |
|
|
2022
Q2 | $11K | Sell |
128
-75
| -37% | -$6.45K | ﹤0.01% | 1868 |
|
|
2022
Q1 | $16K | Sell |
203
-174
| -46% | -$13.7K | ﹤0.01% | 1886 |
|
|
2021
Q4 | $33K | Buy |
377
+141
| +60% | +$12.3K | ﹤0.01% | 1906 |
|
|
2021
Q3 | $18K | Buy |
236
+36
| +18% | +$2.75K | ﹤0.01% | 1885 |
|
|
2021
Q2 | $17K | Sell |
200
-389
| -66% | -$33.1K | ﹤0.01% | 1932 |
|
|
2021
Q1 | $44K | Buy |
+589
| New | +$44K | ﹤0.01% | 1784 |
|